Get our #1 Biotech pick right now

Exclusive Access: The $4 Micro-Cap Set to Soar Exclusive Access: The $4 Micro-Cap Set to Soar                                                                                                      [Morning Watchlist] You are receiving this email because you are subscribed to Behind the Markets. If you no longer wish to receive these emails, please [unsubscribe]( here.  Dear Fellow Investor, We just closed out our Altimmune position for a 125% gain.... Three days before that, we closed out half of our Viking Therapeutics position for a 63% gain... The month before, we closed our Immunogen position for a 463% gain... Well, today I have some great news: We just released our next top biotech pick. [Get the Alert Here before we take it down]( That's because this $4 micro-cap is thinly traded and we want to avoid the "stampede effect" of possibly driving the stock higher. So you have to get in now before we take it down. [Get the name of the stock here ]( Now a lot of our competitors like to cherry-pick their best trades. They want to give you the impression that the gains they're showing you are their average profits. I won't insult your intelligence by doing that. And we don't have to. We've averaged 55.9% gains on closed trades since 2018. [Get the name of the stock here ]( Our mailing address is: Behind the Markets, LLC 4260 NW 1st Avenue, Suite 55 Boca Raton, FL 33431 Copyright © 2024 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our [Privacy Policy]( or our [Legal Notices.]( [Behind the Markets](  [Unsubscribe]( Â